NATALI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 16.397
AS - Asia 8.681
EU - Europa 5.757
SA - Sud America 1.619
AF - Africa 312
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 3
Totale 32.802
Nazione #
US - Stati Uniti d'America 15.906
SG - Singapore 2.733
CN - Cina 2.365
HK - Hong Kong 1.770
IT - Italia 1.639
BR - Brasile 1.355
SE - Svezia 936
BG - Bulgaria 674
VN - Vietnam 621
DE - Germania 501
GB - Regno Unito 434
TR - Turchia 371
CA - Canada 354
RU - Federazione Russa 324
FI - Finlandia 265
UA - Ucraina 229
FR - Francia 202
KR - Corea 159
SM - San Marino 139
IN - India 131
AR - Argentina 102
BD - Bangladesh 93
IE - Irlanda 91
CH - Svizzera 79
CI - Costa d'Avorio 74
MX - Messico 70
IQ - Iraq 64
JP - Giappone 63
AT - Austria 50
ZA - Sudafrica 46
SN - Senegal 45
EC - Ecuador 44
ID - Indonesia 40
UZ - Uzbekistan 39
ES - Italia 36
PL - Polonia 33
MA - Marocco 31
PK - Pakistan 31
SA - Arabia Saudita 31
VE - Venezuela 31
KE - Kenya 28
NL - Olanda 28
AU - Australia 27
BE - Belgio 25
CO - Colombia 25
PY - Paraguay 21
AE - Emirati Arabi Uniti 19
NG - Nigeria 19
CL - Cile 18
EG - Egitto 18
CZ - Repubblica Ceca 17
TT - Trinidad e Tobago 16
TW - Taiwan 16
IR - Iran 14
TN - Tunisia 14
IL - Israele 11
AL - Albania 10
DO - Repubblica Dominicana 10
DZ - Algeria 10
JO - Giordania 10
MY - Malesia 10
NP - Nepal 10
PE - Perù 10
PT - Portogallo 9
UY - Uruguay 9
KZ - Kazakistan 8
LB - Libano 8
PH - Filippine 8
AZ - Azerbaigian 7
JM - Giamaica 7
LT - Lituania 7
PA - Panama 7
PS - Palestinian Territory 7
CR - Costa Rica 6
RO - Romania 6
BJ - Benin 5
ET - Etiopia 5
MN - Mongolia 5
NZ - Nuova Zelanda 5
OM - Oman 5
RS - Serbia 5
SV - El Salvador 5
TH - Thailandia 5
BO - Bolivia 4
GE - Georgia 4
GR - Grecia 4
HN - Honduras 4
AM - Armenia 3
BB - Barbados 3
BH - Bahrain 3
DK - Danimarca 3
EU - Europa 3
LK - Sri Lanka 3
SK - Slovacchia (Repubblica Slovacca) 3
BS - Bahamas 2
BW - Botswana 2
BZ - Belize 2
CD - Congo 2
GA - Gabon 2
HR - Croazia 2
Totale 32.765
Città #
Ashburn 1.802
Hong Kong 1.755
Fairfield 1.657
Singapore 1.500
Woodbridge 1.362
Houston 1.010
Santa Clara 952
Ann Arbor 904
Chandler 845
Dallas 685
Sofia 671
Seattle 653
Shanghai 631
Wilmington 550
Cambridge 527
Beijing 510
Milan 509
New York 416
San Jose 354
Princeton 327
Boardman 325
Ottawa 274
Jacksonville 268
Lawrence 260
Izmir 246
Medford 237
Los Angeles 223
Hefei 191
Serra 187
Nanjing 164
Seoul 154
Ho Chi Minh City 143
Des Moines 112
São Paulo 105
Redondo Beach 103
Florence 101
London 100
Paris 100
Buffalo 99
Pisa 95
Istanbul 93
San Diego 93
Dearborn 80
Dong Ket 80
Nanchang 78
Abidjan 74
Hanoi 71
Bern 70
Lancaster 68
Munich 64
Frankfurt am Main 57
Rio de Janeiro 46
Tokyo 46
Dakar 45
Kunming 41
Ogden 41
Falls Church 40
Jüchen 39
Redwood City 39
The Dalles 38
Changsha 37
San Francisco 36
Shenyang 36
Hebei 35
Columbus 33
Nuremberg 33
Tianjin 33
Turku 33
Belo Horizonte 31
Rome 31
Tashkent 31
Chicago 30
Curitiba 30
Helsinki 30
Vienna 30
Dhaka 28
Lucca 28
Warsaw 28
Brasília 27
Jiaxing 27
Council Bluffs 26
Fuzhou 26
Nairobi 26
Washington 26
Baghdad 25
Düsseldorf 25
Norwalk 25
Toronto 25
Boulder 24
Hangzhou 24
Johannesburg 24
Brussels 22
Orange 22
Guangzhou 21
Phoenix 21
Porto Alegre 21
Wuhan 19
Campinas 18
Lagos 18
Haiphong 17
Totale 23.392
Nome #
Prognostic Value Of 24-hour Ambulatory Blood Pressure And Heart Rate Patterns In Diabetes: A 20-year Longitudinal Analysis Of The Chronic Diabetes Complications And All-cause Mortality In Pisa From 1999 Onwards (CHAMP1ON) Study Cohort 450
Hypertension: a metabolic disorder? 271
Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance 227
Noninvasive measurement of forearm blood flow and oxygen consumption by near-infrared spectroscopy 216
Impact of empagliflozin on subclinical left ventricular dysfunctions and on the mechanisms involved in myocardial disease progression in type 2 diabetes: rationale and design of the EMPA-HEART trial. 198
Insulin resistance and hyperinsulinemia - No independent relation to left ventricular mass in humans 196
Insulin resistance, adipose depots and gut: Interactions and pathological implications 195
Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans - A quantitative study 194
Diabetes and high blood pressure 185
Effects of insulin on the kidney and the cardiovascular system 184
alpha-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population 184
Dietary sodium change in primary aldosteronism. Atrial natriuretic factor, hormonal, and vascular responses. Hypertension. 178
ANF IN PRIMARY ALDOSTERONISM - EFFECT OF DIETARY NA+ AND POSTURAL CHANGES AND RELATIONSHIP WITH ALDOSTERONE 174
A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes 174
Effect of insulin on skeletal muscle metabolism in essential hypertension 171
Independent stimulation of glucose metabolism and Na+-K+ exchange by insulin in the human forearm. 171
Insulin: new roles for an ancient hormone 171
Acute insulin administration does not affect plasma leptin levels in lean or obese subjects 165
Beta-cell function in obesity: effects of weight loss 165
Euglycemic clamp insulin sensitivity and longitudinal systolic blood pressure: role of sex 165
Effect of acute hyperglycemia on insulin secretion in humans 163
Hypertension, insulin resistance, and diabetes 161
Beta-cell function is associated with carotid intima-media thickness independently of insulin resistance in healthy individuals 161
Endothelial dysfunction in type 2 diabetes 160
Effects of short and prolonged mild intracellular nitric oxide manipulations on various aspects of insulin secretion in INS-1E β-cells. 160
Subclinical myopathy in a child with neutral lipid storage disease and mutations in the PNPLA2 gene 159
Insulin sensitivity, vascular reactivity, and clamp-induced vasodilatation in essential hypertension 157
Persistent congestion, renal dysfunction and inflammatory cytokines in acute heart failure: a prognosis study 157
Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database 156
Early metabolic markers of the development of dysglycaemia and type 2 diabetes and their physiological significance 155
Gamma-glutamyltransferase, arterial remodeling and prehypertension in a healthy population at low cardiometabolic risk 154
Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM 152
Gamma-glutamyltransferase, fatty liver index and hepatic insulin resistance are associated with incident hypertension in two longitudinal studies 152
Impact of lowering the criterion for impaired fasting glucose on identification of individuals with insulin resistance. The GISIR database. 151
Hyperinsulinemia and autonomic nervous system dysfunction in obesity - Effects of weight loss 151
Glucose uptake saturation explains glucose kinetics profiles measured by different tests 151
Metformin effects on the heart and the cardiovascular system: A review of experimental and clinical data 150
Metformin is the key factor in elevated plasma growth differentiation factor-15 levels in type 2 diabetes: A nested, case–control study 149
Intestinal glucose absorption is a key determinant of 1-hour postload plasma glucose levels in nondiabetic subjects 149
Cardiovascular organ damage in type 2 diabetes mellitus: The role of lipids and inflammation 148
Assessment of insulin-glucose uptake dose-response characteristics in the non-steady state 147
Insulino Resistenza e Flusso Ematico: Studi con L'Adenosina in Pazienti con Ipertensione Essenziale 146
Influence of duration of obesity on the insulin resistance of obese non-diabetic patients 145
OBEDIS Core Variables Project: European Expert Guidelines on a Minimal Core Set of Variables to Include in Randomized, Controlled Clinical Trials of Obesity Interventions 145
Body Weight, Not Insulin Sensitivity or Secretion, May Predict Spontaneous Weight Changes in Nondiabetic and Prediabetic Subjects The RISC Study 144
Relation of large artery remodelling and distensibility to insulin-resistance in patients with type 2 diabetes 143
Dose-response characteristics of insulin action on glucose metabolism: a non-steady-state approach 143
Determinants of postabsorptive endogenous glucose output in non-diabetic subjects 143
Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on “The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function” 143
Family history of diabetes predisposes to cardiovascular disease among patients with type 2 diabetes: What is the nature of the association? 143
Effect of insulin on skeletal muscle metabolism in essential hypertension 142
Coronary artery disease and stroke in type 2 diabetic patients: possible role of a raised central pulse pressure 141
Measures of atherosclerotic burden are associated with clinically manifest cardiovascular disease in type 2 diabetes: A European cross-sectional study 141
Erythrocyte sedimentation rate, coronary atherosclerosis, and cardiac mortality 140
Impact of incretin hormones on beta-cell function in subjects with normal or impaired glucose tolerance 138
Influence of endogenous NEFA on beta cell function in humans 137
Reciprocal association between insulin sensitivity and the haematocrit in man 137
Autonomic and hemodynamic responses to insulin in lean and obese humans 136
Impaired insulin action on skeletal muscle metabolism in essential hypertension 135
Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy RID F-2315-2010 133
Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension. 133
Carotid artery remodeling and compliance, insulin resistance, and lipid metabolism in type 2 diabetic patients. 132
Insulin sensitivity and fasting insulin: association with indicators of cardiovascular disease in healthy subjects. The RISC Study 132
Anti-inflammatory and Antioxidant Properties of HDLs Are Impaired in Type 2 Diabetes 132
Renovascular hypertension and insulin sensitivity 131
Insulin resistance, insulin response, and obesity as indicators of metabolic risk 131
Insulin resistance of stress: Sites and mechanisms 131
Use of Vascular Assessments and Novel Biomarkers to Predict Cardiovascular Events in Type 2 Diabetes: The SUMMIT VIP Study 131
Association of fasting glucagon and proinsulin concentrations with insulin resistance 130
Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study 130
A novel fasting blood test for insulin resistance and prediabetes 130
A mixed nutrient preload attenuates glucose-induced endothelial dysfunction in individuals with abnormal glucose tolerance 129
Metabolic effects of combined antihypertensive treatment in patients with essential hypertension 128
Measurement of insulin-mediated glucose uptake: Direct comparison of the modified insulin suppression test and the euglycemic, hyperinsulinemic clamp 128
Cardiac Reserve and Exercise Capacity: Insights from Combined Cardiopulmonary and Exercise Echocardiography Stress Testing 128
EFFECTS OF INSULIN ON HEMODYNAMICS AND METABOLISM IN HUMAN FOREARM 127
Triglyceride-rich very low-density lipoproteins (VLDL) are independently associated with insulin secretion in a multiethnic cohort of adolescents 127
Circulating palmitoleic acid is an independent determinant of insulin sensitivity, beta cell function and glucose tolerance in non-diabetic individuals: a longitudinal analysis 126
Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes): A multicenter retrospective nationwide Italian study and crowdsourcing opportunity 125
Muscle metabolism and exercise tolerance in subclinical hypothyroidism: A controlled trial of levothyroxine 124
HDL lipid composition is profoundly altered in patients with type 2 diabetes and atherosclerotic vascular disease. 124
Insulin decreases circulating vitamin E levels in humans 123
The effect of lipoproteins on endothelial nitric oxide synthase is modulated by lipoperoxides 123
Modulation of postprandial glycemic responses by noncarbohydrate nutrients provides novel approaches to the prevention and treatment of type 2 diabetes 123
Effects of Mild Acute Hypertriglyceridemia on Fasting and Post-Load Glucose Homeostasis 123
Effects of angiotensin-converting enzyme inhibition on carbohydrate metabolism and insulin sensitivity in hypertensive patients 122
A genome-wide association study of IVGTT-based measures of first-phase insulin secretion refines the underlying physiology of type 2 diabetes variants 122
Influence of apolipoproteins on the association between lipids and insulin sensitivity: a cross-sectional analysis of the RISC Study 121
Increased gluconeogenesis in NIDDM: Substrate contribution and modulation by lipolysis 120
null 120
A short-term increase in dietary cholesterol and fat intake affects high-density lipoprotein composition in healthy subjects 120
Is hyperglycemia a cardiovascular risk factor? 119
EFFECT OF INSULIN ON URIC-ACID EXCRETION IN HUMANS 119
Value of combined cardiopulmonary and echocardiography stress test to characterize the haemodynamic and metabolic responses of patients with heart failure and mid-range ejection fraction 119
Statins, LDL Cholesterol Control, Cardiovascular Disease Prevention, and Atherosclerosis Progression: A Clinical Perspective 119
LDL resistance to copper-induced oxidation: Effect of LDL lipid composition 118
Hypertension, insulin resistance, and the metabolic syndrome 118
Coronary atherosclerosis in non-insulin-dependent diabetes (NIDDM): Risk factors (RF) and impact on mortality. 117
LDL resistance to oxidation: Effects of lipid phenotype, autologous HDL and alanine 117
Insulin-resistance and triglycerides as independent predictors of the early macrovascular involvement in type 2 diabetic patients 116
Totale 14.940
Categoria #
all - tutte 101.398
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.398


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.134 0 0 0 0 0 0 91 244 147 202 128 322
2021/20222.890 43 145 115 224 534 392 63 171 132 52 150 869
2022/20232.759 400 317 178 201 303 359 23 219 482 32 208 37
2023/20242.458 270 273 334 182 375 421 82 71 46 42 85 277
2024/20258.028 52 331 76 326 635 952 610 484 913 1.107 831 1.711
2025/20266.204 731 1.195 1.075 958 860 906 479 0 0 0 0 0
Totale 33.385